Abstract:If life is to continue, cells that have completed their useful function(s) must die in a timely manner. Apoptosis, programmed cell death, is a natural, orderly, energy-dependent process that causes cells to die without inducing an inflammatory response. In the heart, apoptosis plays pivotal roles in the development of myocarditis, cardiomyopathies, transplant rejection, the periinfarct zone in myocardial infarction, and reperfusion injury. Apoptosis is triggered either by a decrease in factors required to maintain the cell in good health or by an increase in factors which cause damage to the cell. When these factors tilt in the direction of death and the cell has sufficient time to respond, a common proteolytic cascade involving cysteine aspartic acid-specific proteases (caspases) is activated to initiate apoptosis. Cells that die by apoptosis autodigest their DNA and nuclear proteins, change the phospholipid composition on the outer surface of their cell membrane, and form lipid enclosed vesicles, which contain noxious intracellular contents, organelles, autodigested cytoplasm, and DNA. The compositional cell membrane phospholipid change that occurs with the onset of apoptosis is marked by the sudden expression of phosphatidylserine (PS), a phospholipid that ordinarily appears on the inner leaflet of the membrane, on the external leaflet of the membrane. The constant exposure of PS during apoptosis makes it an attractive target for radiopharmaceutical imaging. An endogenous human protein, annexin V, has a high affinity (kd = 7 nmol/L) for PS bound to the cell membrane. Fluorescence-labeled annexin V is used for histologic and cell-sorting studies to identify apoptotic cells. Annexin has been radiolabeled and binds to cells undergoing apoptosis in vivo. This review outlines some of the key features of apoptosis as contrasted to necrosis (unregulated cell death) and describes how these processes can be imaged with radionuclide techniques.

Research Progress of Radionuclide Imaging Probes in Apoptosis

Radionuclide imaging of apoptosis for clinical application

Recent advances in apoptosis imaging using radionuclide-labeled tracers

Progress on molecular imaging for apoptosis

SPECT and PET Radiopharmaceuticals for Molecular Imaging of Apoptosis: from Bench to Clinic

Development Progress of Apoptosis Imaging with Radioactive Annexin V

Progress in Imaging Agents of Cell Apoptosis

Development of small molecular probes for the molecular imaging of apoptosis.

Advance in apoptosis imaging with annexins in tumor research

Evaluation of a Dansyl-Based Amino Acid DNSBA As an Imaging Probe for Apoptosis Detection

Molecular Imaging of Apoptosis: from Micro to Macro.

In vivo detection of apoptotic cell death: a necessary measurement for evaluating therapy for myocarditis, ischemia, and heart failure

Research Progress of Imaging Receptor Tyrosine Kinase Targeted Drugs by Radionuclide

Review Article Design of "smart" Probes for Optical Imaging of Apoptosis

Molecular Imaging of Acute Cardiac Transplant Rejection: Animal Experiments and Prospects.

Regulator-carrying dual-responsive integrated AuNP composite fluorescence probe for in situ real time monitoring apoptosis progression

Design of "smart" Probes for Optical Imaging of Apoptosis

In Vivo Detection of Tumor Apoptosis Using a Novel PET/NIRF Imaging Probe: 18F-Psvue643

Research Progress of Radionuclide Molecular Imaging in Pancreatic Beta Cells

Molecular imaging of cell death in vivo by a novel small molecule probe

Recent Advance on the Ways to Apoptosis Detection